Major depressive disorder (MDD) is the leading cause of disability worldwide. There is an
urgent need for objective biomarkers to diagnose this highly heterogeneous syndrome …

Major depressive disorder (MDD) is predicted to be the second leading cause of global
disease burden by 2030. A large number of MDD patients do not respond to the currently …

Major depression (MD) and bipolar disorder (BD) are severe and potentially life-threating
mood disorders whose etiology is to date not completely understood. MicroRNAs (miRNAs) …

Major depressive disorder (MDD) is a major public health concern. Despite tremendous
advances, the pathogenic mechanisms associated with MDD are still unclear. Moreover, a …

Background: Major depressive disorder (MDD) is a serious and common psychiatric
disorder with a high prevalence in the population. Although great advances have been …

In this review, we discuss the growing field, investigating peripheral miRNAs as potential
biomarkers of major depression and treatment response. A noninvasive and validated …

Currently, diagnosis and treatment of major depressive disorder (MDD) are based on the
patients' description of symptoms, mental status examinations, and clinical behavioral …

Depression is a potentially life-threatening mental disorder affecting approximately 300
million people worldwide. Despite much effort, the molecular underpinnings of clinical …

Depression is a debilitating mental illness that affects up to 120 million people worldwide; it
is currently determined based on subjective diagnostic schemes that are limited by high …

Background Inflammation has been implicated in core features of depression
pathophysiology and treatment resistance. Therefore, new challenges in the discovery of …